Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

(R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depression
Xingming Wang, Jianjun Yang, Kenji Hashimoto
Neuroscience & Biobehavioral Reviews (2022) Vol. 139, pp. 104762-104762
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Arketamine, a new rapid-acting antidepressant: A historical review and future directions
Jichun Zhang, Wei Yao, Kenji Hashimoto
Neuropharmacology (2022) Vol. 218, pp. 109219-109219
Open Access | Times Cited: 69
Emerging role of the host microbiome in neuropsychiatric disorders: overview and future directions
Kenji Hashimoto
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3625-3637
Open Access | Times Cited: 50
Ketamine and its metabolites: Potential as novel treatments for depression
Kai Zhang, Yitan Yao, Kenji Hashimoto
Neuropharmacology (2022) Vol. 222, pp. 109305-109305
Closed Access | Times Cited: 59
Arketamine for cognitive impairment in psychiatric disorders
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1513-1525
Open Access | Times Cited: 32
Neuroinflammation through the vagus nerve-dependent gut–microbiota–brain axis in treatment-resistant depression
Kenji Hashimoto
Progress in brain research (2023), pp. 61-77
Closed Access | Times Cited: 31
Ketamine and its two enantiomers in anesthesiology and psychiatry: A historical review and future directions
Kenji Hashimoto, Mingming Zhao, Tingting Zhu, et al.
Journal of Anesthesia and Translational Medicine (2024) Vol. 3, Iss. 3, pp. 65-75
Open Access | Times Cited: 11
Depression-like phenotypes in mice following common bile duct ligation: Insights into the gut–liver–brain axis via the vagus nerve
Yong Yang, Akifumi Eguchi, Chisato Mori, et al.
Neurobiology of Disease (2024) Vol. 192, pp. 106433-106433
Open Access | Times Cited: 10
(R)-(-)-Ketamine: The Promise of a Novel Treatment for Psychiatric and Neurological Disorders
Hana Shafique, Julie Demers, Julia Biesiada, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6804-6804
Open Access | Times Cited: 9
A role of microRNA-149 in the prefrontal cortex for prophylactic actions of (R)-ketamine in inflammation model
Li Ma, Long Wang, Lijia Chang, et al.
Neuropharmacology (2022) Vol. 219, pp. 109250-109250
Closed Access | Times Cited: 35
Key role of the gut–microbiota–brain axis via the subdiaphragmatic vagus nerve in demyelination of the cuprizone-treated mouse brain
Xingming Wang, Akifumi Eguchi, Yong Yang, et al.
Neurobiology of Disease (2022) Vol. 176, pp. 105951-105951
Open Access | Times Cited: 34
Rapid antidepressant-like effect of non-hallucinogenic psychedelic analog lisuride, but not hallucinogenic psychedelic DOI, in lipopolysaccharide-treated mice
Youge Qu, Lijia Chang, Li Ma, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 222, pp. 173500-173500
Closed Access | Times Cited: 32
Exploring the multifaceted potential of (R)-ketamine beyond antidepressant applications
Senbing Zhang, Yanzhu Pu, Jianning Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Role of oxidative phosphorylation in the antidepressant effects of arketamine via the vagus nerve-dependent spleen-brain axis
Lijia Chang, Wei Yan, Youge Qu, et al.
Neurobiology of Disease (2024) Vol. 199, pp. 106573-106573
Open Access | Times Cited: 7
Transforming growth factor-β1 mediates the beneficial effects of arketamine on demyelination and remyelination in the brains of cuprizone-treated mice
Mingming Zhao, Tingting Zhu, Dan Xu, et al.
European Journal of Pharmacology (2024) Vol. 985, pp. 177096-177096
Open Access | Times Cited: 6
Depression and antidepressant effects of ketamine and its metabolites: The pivotal role of gut microbiota
Hao Hua, Chaoli Huang, Hanyu Liu, et al.
Neuropharmacology (2022) Vol. 220, pp. 109272-109272
Closed Access | Times Cited: 27
Depression-like phenotypes in mice with hepatic ischemia/reperfusion injury: A role of gut–microbiota–liver–brain axis via vagus nerve
Yong Yang, Akifumi Eguchi, Xiayun Wan, et al.
Journal of Affective Disorders (2023) Vol. 345, pp. 157-167
Closed Access | Times Cited: 15
A role of splenic heme biosynthesis pathway in the persistent prophylactic actions of arketamine in lipopolysaccharide-treated mice
Li Ma, Long Wang, Youge Qu, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
A role of gut–brain axis on prophylactic actions of arketamine in male mice exposed to chronic restrain stress
Li Ma, Akifumi Eguchi, Guilin Liu, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 238, pp. 173736-173736
Closed Access | Times Cited: 5
Effects of arketamine on depression-like behaviors and demyelination in mice exposed to chronic restrain stress: A role of transforming growth factor-β1
Dan Xu, Guilin Liu, Mingming Zhao, et al.
Journal of Affective Disorders (2024) Vol. 367, pp. 745-755
Open Access | Times Cited: 5
Ketamine does not rescue plaque load or gap detection in the 5XFAD mouse model of Alzheimer's disease
Anne L. Wright, Aldis P. Weible, Olivia B. Estes, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access
Prophylactic effects of arketamine, but not hallucinogenic psychedelic DOI nor non-hallucinogenic psychedelic analog lisuride, in lipopolysaccharide-treated mice and mice exposed to chronic restrain stress
Guilin Liu, Li Ma, Youge Qu, et al.
Pharmacology Biochemistry and Behavior (2023) Vol. 233, pp. 173659-173659
Closed Access | Times Cited: 12
(S)-Ketamine but Not (R)-Ketamine Shows Acute Effects on Depression-Like Behavior and Sleep-Wake Architecture in Rats
Szabolcs Koncz, Noémi Papp, Dóra Pothorszki, et al.
The International Journal of Neuropsychopharmacology (2023) Vol. 26, Iss. 9, pp. 618-626
Open Access | Times Cited: 11
Effects of perioperative application of esketamine on postpartum depression in cesarean section: A systematic review and meta-analysis
Baoyu Ma, Xinyi Tao, Yanyu Qi, et al.
Medicine (2024) Vol. 103, Iss. 27, pp. e38821-e38821
Open Access | Times Cited: 4
Alzheimer's disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges
Saeid Safiri, Amir Ghaffari Jolfayi, Asra Fazlollahi, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 4
Sense of agency and its disturbances: A systematic review targeting the intentional binding effect in neuropsychiatric disorders
Lorenzo Moccia, Michelangelo Di Luzio, Eliana Conte, et al.
Psychiatry and Clinical Neurosciences (2023) Vol. 78, Iss. 1, pp. 3-18
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top